This approach enabled the detection of the expression of two pancreatic cancer biomarkers, live erythropoietin-producing hepatocellular A 2 (EphA2), and epithelial cell adhesion molecule (EpCAM) [18]. The gene discussed is EPCAM; the disease is familial pancreatic carcinoma.